Alleima Q4 and full-year report 2025

Alleima reported Q4 revenues of SEK 4,494m, down 12% YoY (organic -5%), and rolling 12-month order intake of SEK 17,741m (-9% YoY). Adjusted EBIT fell to SEK 364m (margin 8.1%) with SEK -163m negative currency effects; operating profit was SEK 15m (0.3% margin) after SEK -342m of restructuring/efficiency charges, and diluted EPS was SEK -0.05 (adjusted diluted EPS SEK 1.06). Free operating cash flow was SEK 422m for the quarter (SEK 1,100m FY), the Board proposes a SEK 2.50 dividend, and management flagged continued currency headwinds, production ramp-up impacts in Sandviken, and ongoing restructuring measures alongside capacity and investment projects in China and Malaysia.

Analysis

Market structure: Alleima (ticker ALLEI) is shifting toward winners in high-value niches (medical, nuclear, Kanthal industrial heating) while near-term revenue is hit by weak short-cycle industrial and chemical demand (rolling orders -9%, Q4 organic revenue -5%). Currency translation removed ~SEK 163m of adjusted EBIT in Q4; ex-FX adjusted EBIT margin was ~11.0% vs reported 8.1%, implying operational resilience if FX stabilizes. Competitors focused on commodity stainless (e.g., OUT1V, APAM) are more exposed to cyclical capex and margin compression, widening relative-value opportunities.

Risk assessment: Key tail risks are (1) prolonged European/North American capex freeze reducing short-cycle sales >15% YoY, (2) delayed Sandviken ramp beyond end-2026 (capacity increase +60%) causing multi-quarter margin erosion, and (3) a sharp move in nickel/Cr raw-materials raising COGS; trigger thresholds: adjusted EBIT margin <6% or two consecutive quarters of negative free cash flow would materially change the thesis. Near-term (days–weeks) volatility will track FX and Q1 order commentary; medium-term (3–12 months) hinges on execution of restructuring and plant ramps; long-term (12–36 months) rewards accrue if nuclear/medical ramps hit their capacity/volume targets.

Trade implications: Favor a selective long in ALLEI sized 2–3% of equity risk with a 6–18 month horizon to capture margin recovery and capacity-driven revenue (Sandviken end-2026, Zhenjiang already online). Implement pair trades: long ALLEI vs short OUT1V or APAM to isolate value-added premium; expect spread tightening of 30–40% if Alleima’s strategy executes. Use options to asymmetrically express upside: buy 12-month ALLEI calls (or call spread) sized 50% of equity exposure and buy protective puts (~10% notional) to cap downside.

Contrarian angle: Consensus focuses on near-term revenue weakness and FX pain but underweights capital-light growth in medical and nuclear where structural demand and higher margin contracts can re-rate multiples; the market may be over-penalizing Alleima for cyclical short-cycle exposure. If FX stabilizes and restructuring lowers costs by even SEK 200–300m annually, adjusted EBIT margin can recover toward 10–11%, implying 20–35% upside from depressed levels. Watch for early signs: order intake stabilization over two consecutive months or confirmation of Sandviken restart schedule—these would be rapid re-rating catalysts.

Key Decisions for Investors

• Establish a 2–3% long position in Alleima (ALLEI:ST) with a 6–18 month horizon to capture margin recovery and capacity-driven growth; set a stop-loss if adjusted EBIT margin falls below 6% or two sequential quarters of negative free cash flow occur.
• Enter a relative-value pair: long ALLEI (2% weight) / short Outokumpu (OUT1V:HE) or Aperam (APAM:EN) (2% weight) to isolate specialty/high-value vs commodity stainless exposure; unwind if the spread narrows <15% or if Alleima misses Sandviken restart timeline.
• Buy 12-month ALLEI call options (or call spread) sized at ~50% of the equity position to cap cash outlay and sell shorter-dated calls to finance premium if comfortable with capped upside; simultaneously purchase protective puts equal to ~10% notional as downside insurance.
• Hedge macro and input-risk: reduce net exposure to nickel/chromium price spikes by holding small long positions in SEK (or SEK calls vs EUR) if EUR/SEK depreciates >3% quarter-on-quarter, and consider short nickel futures or buy nickel puts if nickel rallies >20% from current levels.